معرفی
Roland Brosch is the Head of the Integrated Mycobacterial Pathogenomics Unit at the Institut Pasteur in Paris, France. He leads a dynamic research team focused on understanding the genomics, evolution, and pathogenicity of mycobacteria, particularly Mycobacterium tuberculosis. His work is central to uncovering the mechanisms behind the emergence of one of humanity's most persistent pathogens.
His research interests span mycobacterial genomics, the evolution of M. tuberculosis from ancestral forms like M. canettii, the function of ESX secretion systems, host-pathogen interactions, and the development of novel anti-tuberculosis vaccines. His unit's work integrates cutting-edge genomic, phenotypic, and functional analyses to identify virulence factors and drug targets.
The recent publications from his group, including high-impact reviews and original research in journals like PLoS Pathogens, PLoS Biology, and FEMS Microbiology Reviews, reveal a strong focus on the evolutionary trajectory of TB, the discovery of novel environmental mycobacteria as evolutionary 'missing links', the development of rapid diagnostics like TRACeR-TB, and the exploration of host-directed therapies. This indicates a research program at the forefront of both basic mycobacterial biology and translational applications.
Roland Brosch is the Principal Investigator (PI) for major international research consortia, including PreDiCT-TB (focused on drug combination discovery) and TBVAC2020 (focused on next-generation TB vaccines). His unit also participates in the Labex IBEID initiative on emerging infectious diseases, highlighting the broad impact of his work. He mentors a diverse team of PhD students, postdoctoral researchers, and engineers, fostering the next generation of scientists in the field of infectious diseases.
His laboratory, located at 25-28 Rue du Docteur Roux, is a hub for research on mycobacterial pathogenesis, contributing significantly to the global effort to combat tuberculosis through fundamental scientific discovery.
